Since GBM CSCs are characterized by increased resistance to TMZ [32], YTHDF1 knockdown-mediated reduction of CSCs may explain the elevated sensitivity of GBM cells to this drug (Fig. 2d). Here, YTHDF1 is linked to glioblastoma.